Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimen-Reference-Cited by-同舟云学术

Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimen

Published:2018-01-12 Issue:4 Volume:73 Page:1039-1044
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Charpentier Charlotte¹,Malet Isabelle²³,Andre-Garnier Elisabeth⁴,Storto Alexandre¹,Bocket Laurence⁵,Amiel Corinne⁶,Morand-Joubert Laurence⁷,Tumiotto Camille⁸,Nguyen Thuy²³,Maillard Anne⁹,Rodallec Audrey⁴,Leoz Marie¹⁰,Montes Brigitte¹¹,Schneider Véronique⁶,Plantier Jean-Christophe¹⁰,Dina Julia¹²,Pallier Coralie¹³,Mirand Audrey¹⁴,Roussel Catherine¹⁵,Signori-Schmuck Anne¹⁶,Raymond Stéphanie¹⁷,Calvez Vincent²³,Delaugerre Constance¹⁸,Marcelin Anne-Geneviève²³,Descamps Diane¹

Affiliation:

1. IAME, UMR 1137, INSERM, Université Paris Diderot, Sorbonne Paris Cité, AP-HP, Laboratoire de Virologie, Hôpital Bichat, AP-HP, Paris, France

2. Sorbonne University, UPMC Univ Paris 06, INSERM, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris, France

3. AP-HP, Laboratoire de Virologie, Hôpital La Pitié Salpêtrière, Paris, France

4. CHU Nantes, Laboratoire de Virologie, Nantes, France

5. CHRU Lille, Laboratoire de Virologie, Lille, France

6. Hôpital Tenon, Laboratoire de Virologie, Paris, France

7. Sorbonne Universités, UPMC Université Paris 06, INSERM, Institut Pierre Louis d’épidémiologie et de Santé Publique (IPLESP UMRS 1136), F75013, Paris, France; AP-HP, Centre Hospitalo-Universitaire Saint-Antoine, Laboratoire de Virologie, F-75012, Paris, France

8. CHU Bordeaux, Laboratoire de Virologie, Bordeaux, France

9. CHU Rennes, Laboratoire de Virologie, Rennes, France

10. CHU Rouen, Laboratoire de Virologie, Rouen, France

11. CHU Montpellier, Laboratoire de Virologie, Montpellier, France

12. CHU Caen, Laboratoire de Virologie, Caen, France

13. Hôpital Paul Brousse, Laboratoire de Virologie, Villejuif, France

14. CHU Clermont-Ferrand, Laboratoire de Virologie, Clermont-Ferrand, France

15. CHU Amiens, Laboratoire de Virologie, Amiens, France

16. CHU Grenoble, Laboratoire de Virologie, Grenoble, France

17. CHU Toulouse, Laboratoire de Virologie, Toulouse, France

18. Hôpital St Louis, Laboratoire de Virologie, Paris, France

Funder

Agence Nationale de Recherches sur le Sida et les Hepatites Virales

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/73/4/1039/24269615/dkx511.pdf

Reference13 articles.

1. The HIV-1 integrase E157Q polymorphism per se does not alter susceptibility to raltegravir and dolutegravir in vitro;Saladini;AIDS,2017

2. Mutations associated with failure of raltegravir treatment affect integrase sensitivity to the inhibitor in vitro;Malet;Antimicrob Agents Chemother,2008

3. Rapid selection and archiving of mutation E157Q in HIV-1 DNA during short-term low-level replication on a raltegravir-containing regimen;Ghosn;J Antimicrob Chemother,2009

4. Non-virological response to a dolutegravir-containing regimen in a patient harbouring a E157Q-mutated virus in the integrase region;Danion;J Antimicrob Chemother,2015

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrase strand transfer inhibitor resistance mediated by R263K plus E157Q in a patient with HIV infection treated with bictegravir/tenofovir alafenamide/emtricitabine: case report and review of the literature;Journal of Antimicrobial Chemotherapy;2024-04-01

2. Pretreatment integrase strand transfer inhibitor resistance in Tianjin, China;Chinese Medical Journal;2023-11-03

3. Virological outcomes of various first-line ART regimens in patients harbouring HIV-1 E157Q integrase polymorphism: a multicentre retrospective study;Journal of Antimicrobial Chemotherapy;2023-10-19

4. Identification of integrase inhibitor-related drug resistance mutations in newly diagnosed ART-naïve HIV patients;Microbial Pathogenesis;2023-08

5. Prevalence of Transmitted Drug Resistance among HIV-1 Patients in the Aegean Region: Results from the Western Part of Turkey;Current HIV Research;2023-03